Loading cancer entity…
Loading cancer entity…
Clinical trials
10,627 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,641)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00742495 | Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.(BCX1777-108) | terminated | Phase 1 / Phase 2 | 2 | Mundipharma Research LimitedINDUSTRY | 6 | Oct 24, 2012 | clinicaltrials |
| NCT00355472 | Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL | completed | Phase 1 | 16 | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | Oct 18, 2012 |
| clinicaltrials |
| NCT00972101 | Infusion of Expanded Cord Blood T Cells | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 11, 2012 | clinicaltrials |
| NCT01409148 | Radioimmunoimaging of AL Amyloidosis | completed | Phase 1 | 38 | University of TennesseeOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00920855 | Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma | completed | Phase 1 / Phase 2 | 40 | CephalonINDUSTRY | 1 | Oct 4, 2012 | clinicaltrials |
| NCT01300793 | Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide(V-RICE) | terminated | Phase 1 | 6 | University of California, San FranciscoOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00677105 | A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. | completed | Phase 1 | 92 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00710528 | Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies | completed | Phase 1 | 192 | Gilead SciencesINDUSTRY | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00793650 | Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study | terminated | Phase 1 / Phase 2 | 39 | Emory UniversityOTHER | 1 | Aug 30, 2012 | clinicaltrials |
| NCT00397800 | Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 12 | Technical University of MunichOTHER | 1 | Aug 28, 2012 | clinicaltrials |
| NCT00360438 | Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS | completed | Phase 1 / Phase 2 | 18 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00939172 | TTP607 in Refractory Solid Malignancies | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 31, 2012 | clinicaltrials |
| NCT00303199 | Study of ZIO-101 in Multiple Myeloma | completed | Phase 1 / Phase 2 | 35 | Alaunos TherapeuticsINDUSTRY | 2 | Jul 19, 2012 | clinicaltrials |
| NCT00592046 | A Phase I Trial of ZIO-101 in Hematologic Cancers | completed | Phase 1 | 12 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT01139359 | Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma | withdrawn | Phase 1 | 0 | Alaunos TherapeuticsINDUSTRY | 0 | Jul 19, 2012 | clinicaltrials |
| NCT00796731 | SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma | completed | Phase 1 | 77 | SanofiINDUSTRY | 1 | Jul 17, 2012 | clinicaltrials |
| NCT00439361 | Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma | completed | Phase 1 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT00415064 | Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma | completed | Phase 1 | 32 | AEterna ZentarisINDUSTRY | 1 | Jul 6, 2012 | clinicaltrials |
| NCT00660166 | Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions | completed | Phase 1 | 13 | Tufts Medical CenterOTHER | 1 | Jun 27, 2012 | clinicaltrials |
| NCT00886496 | Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia | withdrawn | Phase 1 | 0 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00004898 | Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia | completed | Phase 1 / Phase 2 | 6 | Northwestern UniversityOTHER | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00004907 | Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00575068 | Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 42 | BiogenINDUSTRY | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00004916 | Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00006225 | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00186589 | 90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL | completed | Phase 1 | 30 | Stanford UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004904 | Stem Cell Transplantation in Treating Patients With Hematologic Cancer | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT00004232 | Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT00005787 | Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma | terminated | Phase 1 | 3 | Northwestern UniversityOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT00058292 | Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | completed | Phase 1 | 44 | Northwestern UniversityOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT01010243 | Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial(MM03) | unknown | Phase 1 / Phase 2 | 54 | University of RegensburgOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT00383097 | Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma(ALDI) | terminated | Phase 1 | 6 | Baylor College of MedicineOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT00779337 | Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas(EPL) | completed | Phase 1 | 8 | Queensland Institute of Medical ResearchOTHER | 1 | May 22, 2012 | clinicaltrials |
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00647764 | Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas | completed | Phase 1 | 32 | Esanex Inc.INDUSTRY | 1 | May 17, 2012 | clinicaltrials |
| NCT00004212 | DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00234169 | A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone | completed | Phase 1 / Phase 2 | 30 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 10, 2012 | clinicaltrials |
| NCT00472368 | A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589 | completed | Phase 1 | 4 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2012 | clinicaltrials |
| NCT00741871 | A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies | completed | Phase 1 | 35 | S*BIOINDUSTRY | 1 | Apr 20, 2012 | clinicaltrials |
| NCT00089453 | Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant | completed | Phase 1 | 10 | University of ArkansasOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00734890 | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 18 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00031941 | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00088868 | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma | completed | Phase 1 | 40 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00387608 | ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer | completed | Phase 1 | 23 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00064311 | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00080925 | T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies | completed | Phase 1 | 20 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00589381 | Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Oct 24, 2012source: clinicaltrials